Logo

Genaissance Pens PGx Agreement with Ferring Pharmaceuticals

Dec 11, 2003

NEW YORK, Dec. 11 (GenomeWeb News) - Genaissance Pharmaceuticals will provide Ferring Pharmaceuticals certain pharmacogenomic services and technology, the companies said today.

Terms of the agreement call for Genaissance to provide Ferring its DNA banking services through its Morrisville, NC, facility. Genaissance will also collaborate with Ferring to identify clinical projects for the application of its HAP technology.

Breaking News
The Scan

Vaccine Update Recommended

A US Food and Drug Administration panel recommends booster vaccines be updated to target Omicron, CNBC reports.

US to Make More Vaccines for Monkeypox Available

The US is to make nearly 300,000 vaccine doses available in the coming weeks to stem the spread of human monkeypox virus, according to NPR.

Sentence Appealed

The Associated Press reports that Swedish prosecutors are appealing the sentence given to a surgeon once lauded for transplanting synthetic tracheas but then convicted of causing bodily harm.

Genome Biology Papers on COVID-19 Effector Genes, Virtual ChIP-seq, scDART

In Genome Biology this week: proposed COVID-19 effector genes, method to predict transcription factor binding patterns, and more.